Add-on Therapy With the α-Blockers Tamsulosin and Naftopidil Improves Voiding Function by Enhancing Neuronal Activity in Prostatic Hyperplasia Rats
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Purpose: Benign prostatic hyperplasia (BPH) impacts quality of life in men by causing lower urinary tract symptoms. α1- Adrenoceptor (α1-AR) blockers improve lower urinary tract symptoms. We investigated the efficacy of add-on therapy with α1-AR blockers on BPH rats. Methods: Rats in the drug-treated groups were orally administered each drug once a day for 30 days after orchiectomy. To induce BPH, rats were castrated and testosterone (20 mg/kg) was injected subcutaneously once per day for 30 days. Cystometry was conducted to measure voiding contraction pressure and the interval contraction time, immunohistochemistry was performed to measure c-Fos and nerve growth factor (NGF) expression in the neuronal voiding centers, and nicotinamide adenine dinucleotide phosphate-diaphorase histochemistry was used to measure nitric oxide synthase (NOS) expression. Results: Orchiectomy and testosterone injection decreased voiding contraction pressure and the interval contraction time, suggesting BPH symptoms. Voiding contraction pressure and the interval contraction time were greater in the group that received the combination treatment (tamsulosin with naftopidil) than in the tamsulosin monotherapy or naftopidil monotherapy groups. c-Fos, NGF, and NOS expression in the neuronal voiding centers was enhanced by BPH induction. c-Fos, NGF, and NOS expression was suppressed by the combination treatment (tamsulosin with naftopidil) to a greater extent than was the case for tamsulosin monotherapy or naftopidil monotherapy. Conclusions: Combination therapy of tamsulosin and naftopidil showed greater efficacy for the treatment of BPH than tamsulosin monotherapy or naftopidil monotherapy; therefore, combination therapy can be considered as a novel therapeutic method for BPH.
Abstract
Purpose: Benign prostatic hyperplasia (BPH) impacts quality of life in men by causing lower urinary tract symptoms. α1- Adrenoceptor (α1-AR) blockers improve lower urinary tract symptoms. We investigated the efficacy of add-on therapy with α1-AR blockers on BPH rats. Methods: Rats in the drug-treated groups were orally administered each drug once a day for 30 days after orchiectomy. To induce BPH, rats were castrated and testosterone (20 mg/kg) was injected subcutaneously once per day for 30 days. Cystometry was conducted to measure voiding contraction pressure and the interval contraction time, immunohistochemistry was performed to measure c-Fos and nerve growth factor (NGF) expression in the neuronal voiding centers, and nicotinamide adenine dinucleotide phosphate-diaphorase histochemistry was used to measure nitric oxide synthase (NOS) expression. Results: Orchiectomy and testosterone injection decreased voiding contraction pressure and the interval contraction time, suggesting BPH symptoms. Voiding contraction pressure and the interval contraction time were greater in the group that received the combination treatment (tamsulosin with naftopidil) than in the tamsulosin monotherapy or naftopidil monotherapy groups. c-Fos, NGF, and NOS expression in the neuronal voiding centers was enhanced by BPH induction. c-Fos, NGF, and NOS expression was suppressed by the combination treatment (tamsulosin with naftopidil) to a greater extent than was the case for tamsulosin monotherapy or naftopidil monotherapy. Conclusions: Combination therapy of tamsulosin and naftopidil showed greater efficacy for the treatment of BPH than tamsulosin monotherapy or naftopidil monotherapy; therefore, combination therapy can be considered as a novel therapeutic method for BPH.
참고문헌 (30)
- Ishii K, "Identification of a new pharmacological activity of the phenylpiperazine d erivative naftopidil: tubulin-binding drug", J Chem Biol, 8, pp.5~9 (2014)
- Fowler CJ, "Integrated control of lower urinary tract--clinical perspective", Br J Pharmacol, 147(Suppl 2), pp.S14~S24 (2006)[DOI]
- Ku JH, "Correlation between prostatic urethral angle and bladder outlet obstruction index in patients with lower urinary tract symptoms", Urology, 75, pp.1467~1471 (2010)[DOI]
- Kang M, "Association of high bladder neck elevation with urodynamic bladder outlet obstruction in patients with lower urinary tract symptoms and benign prostatic hyperplasia", Urology, 84, pp.1461~1466 (2014)[DOI]
- Kawai Y, "Effects of the phosphodiesterase 5 inhibitor Tadalafil on bladder function in a rat model of partial bladder outlet obstruction", Neurourol Urodyn, 35, pp.444~449 (2016)[DOI]
- Yuan J, "The efficacy and safety of alpha-1 blockers for benign prostatic hyperplasia: an overview of 15 systematic reviews", Curr Med Res Opin, 29, pp.279~287 (2013)[DOI]
- Homma Y, "Outline of JUA clinical guidelines for benign prostatic hyperplasia", Int J Urol, 18, pp.741~756 (2011)[DOI]
- Kim HJ, "Efficacy and safety of initial combination treatment of an alpha blocker with an anticholinergic medication in benign prostatic hyperplasia patients with lower urinary tract symptoms: updated meta-analysis", PLoS One, 12, pp.e0169248~ (2017)[DOI]
- Kim SK, "Inhibitory effect of curcumin on testosterone induced benign prostatic hyperplasia rat model", BMC Complement Altern Med, 15, pp.380~ (2015)[DOI]
- 김성은, "Effects of Tamsulosin on Urinary Bladder Function and Neuronal Activity in the Voiding Centers of Rats with Cyclophosphamide-induced Overactive Bladder", International Neurourology Journal, 16(1), pp.13~22 (2012), 대한배뇨장애요실금학회
- Long-Hu Jin, "Flow Starting Point and Voiding Mechanisms Measured by Simultaneous Registrations of Intravesical, Intra-abdominal, and Intraurethral Pressures in Awake Rats", International Neurourology Journal, 18(2), pp.68~76 (2014), 대한배뇨장애요실금학회
- 고일규, "Effects of Combination Treatment of Alpha 1-Adrenergic Receptor Antagonists on Voiding Dysfunction: Study on Target Organs in Overactive Bladder Rats", International Neurourology Journal, 20, pp.150~158 (2016), 대한배뇨장애요실금학회
- Oudot A, "A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat", BJU Int, 110, pp.1352~1358 (2012)[DOI]
- Miao M, "The effect of Leonuri Herba alkaloids on senile BPH (male and female hormone induced) model rats", Saudi J Biol Sci, 24, pp.630~633 (2017)[DOI]
- Lepor H, "Alpha 1 adrenoceptor subtypes in the human prostate", J Urol, 149, pp.640~642 (1993)[DOI]
- Nascimento-Viana JB, "New muli-target antagonists of <TEX>${\alpha}1A$<", TEX>-, <TEX>${\alpha}1D$<, J Pharmacol Exp Ther, pp.2016, 356[DOI]
- Nishino Y, "Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study", BJU Int, 97, pp.747~751 (2006)[DOI]
- Griwan MS, "Comparative evaluation of naftopidil and tamsulosin in the treatment of patients with lower urinary tract symptoms with benign prostatic hyperplasia", Urol Ann, 6, pp.181~186 (2014)[DOI]
- Athanasopoulos A, "Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study", J Urol, 169, pp.2253~2256 (2003)[DOI]
- Jeong MS, "The role of spinal and peripheral alpha1- and alpha2- adrenoceptors on bladder activity induced by bladder distension in anaesthetized rat", BJU Int, 85, pp.925~931 (2000)
- 김성은, "Alpha1-adrenergic receptor antagonist tamsulosin ameliorates aging-induced memory impairment by enhancing neurogenesis and suppressing apoptosis in the hippocampus of old-aged rats", Animal Cells and Systems, 21(6), pp.404~411 (2017), 한국통합생물학회[DOI]
- Vignes JR, "Sacral neuromodulation in lower urinary tract dysfunction", Adv Tech Stand Neurosurg, 30, pp.177~224 (2005)
- Kitta T, "Brain-bladder control network: the unsolved 21st century urological mystery", Int J Urol, 22, pp.342~348 (2015)[DOI]
- Rickey LM, "Estrogen-sensitive projections from the medial preoptic area to the dorsal pontine tegmentum, including Barrington's nucleus, in the rat", Neurourol Urodyn, 27, pp.440~445 (2008)[DOI]
- Lee TH, "Dependence of rat hippocampal c-Fos expression on intensity and duration of exercise", Life Sci, 72, pp.1421~1436 (2003)[DOI]
- Keay KA, "Convergence of deep somatic and visceral nociceptive information onto a discrete ventrolateral midbrain periaqueductal gray region", Neuroscience, 61, pp.727~732 (1994)[DOI]
- Chung IM, "Effects of acupuncture on abdominal leak point pressure and c-Fos expression in the brain of rats with stress urinary incontinence", Neurosci Lett, 439, pp.18~23 (2008)[DOI]
- Ho MH, "Physiologic role of nitric oxide and nitric oxide synthase in female lower urinary tract", Curr Opin Obstet Gynecol, 16, pp.423~429 (2004)[DOI]
- Pandita RK, "Capsaicin-induced bladder overactivity and nociceptive behaviour in conscious rats: involvement of spinal nitric oxide", J Auton Nerv Syst, 67, pp.184~191 (1997)[DOI]
- Nazif O, "Neural upregulation in interstitial cystitis", Urology, 69(4 Suppl), pp.24~33 (2007)[DOI]